 |
| Invirion Launches First Quantitative HPV E6, E7 Assay and Announces CE Mark and Approval for Reimbursement in Spain More |
Invirion Diagnostics, LLC Announces
Release of Newest Reagent Kit
More |
| Dr. Bruce Patterson, Founder of
Invirion, presented “Viral Diagnostic Assays Using
Flow Cytometry” in a Plenary session of the Clinical
Virology Symposium, Clearwater, FL May 2006. |
| Invirion, Inc. Forms Strategic Partnership
with Worldwide AIDS Coalition (WWAC) In Fight Against
HIV/AIDS in Africa More |
|
| is the first theranostics company
dedicated to the detection, monitoring and treatment of
life-threatening viral diseases such as HIV/AIDS, cervical
cancer, and organ transplant rejection. Invirion, Inc.
was founded in 1999 with the goal of commercializing state-of-the-art
molecular virology technology to make a difference in
people’s lives. Invirion’s research, development,
and commercialization efforts are focused on monitoring
viruses that cause human disease and using the information
gleaned from these novel assays to develop therapeutic
products that rationally target the viral lifecycle. |
|
